Cover Image
市場調查報告書

藥物安全性監視軟體的全球市場:各功能 (藥物有害反應 (ADR) 報告軟體,藥物安全性審核,安全性情報追蹤,綜合軟體),各提供形態 (內部部署,隨選),及各用途市場分析,以及各領域的未來預測

Pharmacovigilance Software Market By Functionality (ADR Reporting Software, Drug Safety Audits, Issue Tracking, Fully Integrated Software), By Delivery Mode (On-Premise, On-Demand), By End-Use And Segment Forecasts To 2024

出版商 Grand View Research, Inc. 商品編碼 374616
出版日期 內容資訊 英文 100 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
藥物安全性監視軟體的全球市場:各功能 (藥物有害反應 (ADR) 報告軟體,藥物安全性審核,安全性情報追蹤,綜合軟體),各提供形態 (內部部署,隨選),及各用途市場分析,以及各領域的未來預測 Pharmacovigilance Software Market By Functionality (ADR Reporting Software, Drug Safety Audits, Issue Tracking, Fully Integrated Software), By Delivery Mode (On-Premise, On-Demand), By End-Use And Segment Forecasts To 2024
出版日期: 2016年10月04日 內容資訊: 英文 100 Pages
簡介

本報告以藥物安全性監視軟體的全球市場為研究主題,提供推動市場成長要素,阻礙因素,市場機會,市場競爭情形等總括性檢驗,目前市場方案分析與今後的市場預測。

第1章 調查手法及調查範圍

  • 各地區市場規模估計
    • 地區市場:基礎的預算
    • 全球市場:年複合成長率估計
  • 各地區市場佔有率估計
  • 二次資料來源一覽

第2章 摘要整理

第3章 市場概況

第4章 市場變數,趨勢,及範圍

  • 市場分類及範圍
  • 推動市場成長要素分析
  • 阻礙市場成長要素分析
  • 普及率及成長度預測製圖
  • 藥物安全性監視軟體的PESTEL分析
  • 產業分析 - 波特的五力分析

第5章 市場分析類別1:各功能市場規模預算及趨勢分析

  • 藥物安全性監視軟體市場:功能趨勢分析
  • 藥物有害反應 (ADR) 報告軟體
    • ADR報告軟體市場
  • 藥物安全性審核
    • 藥物安全性審核市場
  • 安全性情報追蹤
    • 安全性情報追蹤市場
  • 綜合軟體
    • 綜合軟體市場

第6章 市場分析類別2:提供各形態市場規模預算及趨勢分析

  • 藥物安全性監視軟體市場:提供形態趨勢分析
  • 內部部署
    • 內部部署市場
  • 隨選
    • 隨選市場

第7章 市場分析類別3:各用途市場規模預算及趨勢分析

  • 藥物安全性監視軟體市場:各用途趨勢分析
  • 製藥及生物技術企業
    • 製藥及生物技術企業市場
  • CRO (醫藥品臨床研究委外機構)
    • CRO市場
  • BPO (業務流程外包)
    • BPO市場
  • 其他
    • 其他的市場

第8章 市場分析類別4:各地區市場規模預算及各功能,各提供形態,各用途趨勢分析

  • 各地區藥物安全性監視軟體市場佔有率
  • 北美
    • 北美藥物安全性監視軟體市場
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲藥物安全性監視軟體市場
    • 英國
    • 德國
  • 亞太地區
    • 亞太地區藥物安全性監視軟體市場
    • 日本
    • 中國
    • 印度
  • 南美
    • 南美藥物安全性監視軟體市場
    • 巴西
    • 墨西哥
  • 中東及非洲地區
    • 中東、非洲地區藥物安全性監視軟體市場
    • 南非

第9章 市場競爭情形

  • 主要企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GVR-1-68038-144-3

The global pharmacovigilance (PV) software market was valued at USD 117.3 million in 2015 and is expected to reach a value of USD 207.3 million by 2024. Increasing emphasis on regulatory compliances by government entities such as the U.S. FDA, European Medical Agency, etc. coupled with supportive initiatives are anticipated to drive the PV software market over the forecast period.

Increasing demand for fully integrated systems in an attempt to avert errors in database management is a crucial factor responsible for the adoption of these systems. Moreover, associated benefits of cloud-based platforms, such as remote access to information, reduction of operational costs, and ease of access are factors contributing toward the market growth in the near future.

Further Key Findings from the Study Suggest:

ADR reporting tools dominated the overall pharmacovigilance software market on the basis of functionality in 2015, due to the related benefits such as data entry and management with minimum errors. On the other hand, demand for fully integrated platforms is increasing to track individual case safety reports and avoid data redundancy through the elimination of errors. The aforementioned factors are anticipated to contribute toward lucrative growth of fully integrated systems in PV.

On-demand software services, considered as cloud computing are expected to be the fastest growing service segment in the coming years due to its increasing adoption in the contract research organizations. Remote access to data, real-time data tracking, and a simpler complex physical ecosystem are the notable benefits associated with cloud-based systems.

CROs segment is expected to exhibit profitable growth during the forecast period due to the increasing trend of outsourcing. PV service providers, in an attempt, to ensure sustainability, are providing customized end-to-end solutions to meet consumer needs. These firms are also incorporating integrated technologies, such as electronic data capture and hosting of PV warehousing to aggregate cross industry data, which enables risk evaluation. Furthermore, service providers are now operating via flexible and variable pricing structures to achieve operational excellence through constant product updates, which is expected to boost the usage rates over the next 7 years.

North America held the largest market share as of 2015, majorly owing to the government aided initiatives favoring the adoption of PV software systems. For instance, the Open FDA initiative provides scientists and application developers the access to its massive database through open search-based programs, which is anticipated to boost the usage rates over the forecast period. Mini-Sentinel is a project started by the U.S. FDA to promote active surveillance systems, which provide statistically relevant data in less time. The aforementioned initiatives strengthen the growth of the regional market

Many healthcare IT companies are shifting toward hosting of cloud-based platforms to gain an edge over the competition. Cloud-based technology helps in remote storage of large amounts of data to save free space on the devices and facilitates data retrieval as per client needs. The technology comprises 3 services including Platform as a Service (PaaS), Infrastructure as a Service (IaaS), and Software as a Service (SaaS)

The key players serving pharmacovigilance software market are ArisGlobal, Ennov Solutions Inc.,Oracle Corporation, AB Cube, Sparta Systems, Inc., Max Application, EXTEDO GmbH, Relsys, Online Business Applications, Inc., and United BioSource Corporation

Table of Content

Chapter 1. Research Methodology & Scope

  • 1.1. Region Wise Market Calculation
    • 1.1.1. Region Wise Market: Base Estimates
    • 1.1.2. Global Market: CAGR Calculation
  • 1.2. Region Based Segment Share Calculation
  • 1.3. List of Secondary Sources

Chapter 2. Executive Summary

Chapter 3. Market Snapshot

Chapter 4. Market Variables, Trends & Scope

  • 4.1. Market Segmentation & Scope
    • 4.1.1. Market driver analysis
      • 4.1.1.1. Rising incidences of ADR
      • 4.1.1.2. Globalization of pharmacovigilance
      • 4.1.1.3. Increasing burden from regulatory authorities
      • 4.1.1.4. Introduction of technologically advanced software services
    • 4.1.2. Market restraint analysis
      • 4.1.2.1. Expensive technology
  • 4.2. Penetration & Growth Prospect Mapping
  • 4.3. Pharmacovigilance Software-PESTLE Analysis
  • 4.4. Industry Analysis-Porter's

Chapter 5. Market Categorization 1: Functionality Estimates & Trend Analysis

  • 5.1. Pharmacovigilance Software Market: Functionality Movement Analysis
  • 5.2. ADR Reporting Software
    • 5.2.1. ADR reporting software market, 2013-2024(USD Million)
  • 5.3. Drug Safety Audits
    • 5.3.1. Drug safety audits market, 2013-2024(USD Million)
  • 5.4. Issue Tracking
    • 5.4.1. Issue tracking market, 2013-2024(USD Million)
  • 5.5. Fully Integrated Software
    • 5.5.1. Fully integrated software market, 2013-2024(USD Million)

Chapter 6. Market Categorization 2: Delivery Mode Estimates & Trend Analysis

  • 6.1. Pharmacovigilance Software Market: Delivery Mode Movement Analysis
  • 6.2. On-premise
    • 6.2.1. On-premise market, 2013-2024(USD Million)
  • 6.3. On-demand
    • 6.3.1. On-demand market, 2013-2024(USD Million)

Chapter 7. Market Categorization 3: End-use Estimates & Trend Analysis

  • 7.1. Pharmacovigilance Software Market: End-use Movement Analysis
  • 7.2. Pharma & Biotech Companies
    • 7.2.1. Pharma & biotech companies market, 2013-2024(USD Million)
  • 7.3. CROs
    • 7.3.1. CROs market, 2013-2024(USD Million)
  • 7.4. BPOs
    • 7.4.1. BPOs market, 2013-2024(USD Million)
  • 7.5. Others
    • 7.5.1. Others market, 2013-2024(USD Million)

Chapter 8. Market Categorization 4: Regional Estimates & Trend Analysis, by Functionality, Delivery Mode, and End-use

  • 8.1. Pharmacovigilance Software Market Share by Region, 2015KKKKK & 2024
  • 8.2. North America
    • 8.2.1. North America pharmacovigilance software market, 2013-2024(USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. pharmacovigilance software market, 2013-2024(USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Canada pharmacovigilance software market, 2013-2024(USD Million)
  • 8.3. Europe
    • 8.3.1. Europe pharmacovigilance software market, 2013-2024(USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK pharmacovigilance software market, 2013-2024(USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Germany pharmacovigilance software market, 2013-2024(USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Pharmacovigilance software market, 2013-2024(USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan pharmacovigilance software market, 2013-2024(USD Million)
    • 8.4.3. China
      • 8.4.3.1. China pharmacovigilance software market, 2013-2024(USD Million)
    • 8.4.4. India
      • 8.4.4.1. India Pharmacovigilance software market, 2013-2024(USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Pharmacovigilance software market, 2013-2024(USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Pharmacovigilance software market, 2013-2024(USD Million)
    • 8.5.3. Mexico
      • 8.5.3.1. Mexico Pharmacovigilance software market, 2013-2024(USD Million)
  • 8.6. MEA
    • 8.6.1. MEA pharmacovigilance software market, 2013-2024(USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa pharmacovigilance software market, 2013-2024(USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Profiles
    • 9.1.1. AB cube
      • 9.1.1.1. Company Overview
      • 9.1.1.2. Financial Performance
      • 9.1.1.3. Product Benchmarking
      • 9.1.1.4. Strategic Initiatives
    • 9.1.2. Max Application
      • 9.1.2.1. Company Overview
      • 9.1.2.2. Financial Performance
      • 9.1.2.3. Product Benchmarking
      • 9.1.2.4. Strategic Initiatives
    • 9.1.3. Ennov Solutions, Inc.
      • 9.1.3.1. Company Overview
      • 9.1.3.2. Financial Performance
      • 9.1.3.3. Product Benchmarking
      • 9.1.3.4. Strategic Initiatives
    • 9.1.4. ArisGlobal
      • 9.1.4.1. Company Overview
      • 9.1.4.2. Financial Performance
      • 9.1.4.3. Product Benchmarking
      • 9.1.4.4. Strategic Initiatives
    • 9.1.5. EXTEDO GmbH
      • 9.1.5.1. Company Overview
      • 9.1.5.2. Financial Performance
      • 9.1.5.3. Product Benchmarking
      • 9.1.5.4. Strategic Initiatives
    • 9.1.6. Online Business Applications, Inc.
      • 9.1.6.1. Company Overview
      • 9.1.6.2. Financial Performance
      • 9.1.6.3. Product Benchmarking
      • 9.1.6.4. Strategic Initiatives
    • 9.1.7. Oracle Corporation
      • 9.1.7.1. Company Overview
      • 9.1.7.2. Financial Performance
      • 9.1.7.3. Product Benchmarking
      • 9.1.7.4. Strategic Initiatives
    • 9.1.8. Sparta Systems, Inc.
      • 9.1.8.1. Company Overview
      • 9.1.8.2. Financial Performance
      • 9.1.8.3. Product Benchmarking
      • 9.1.8.4. Strategic Initiatives
    • 9.1.9. United BioSource Corporation
      • 9.1.9.1. Company Overview
      • 9.1.9.2. Financial Performance
      • 9.1.9.3. Product Benchmarking
      • 9.1.9.4. Strategic Initiatives
    • 9.1.10. Relsys
      • 9.1.10.1. Company Overview
      • 9.1.10.2. Financial Performance
      • 9.1.10.3. Product Benchmarking
      • 9.1.10.4. Strategic Initiatives

List of Tables

  • TABLE 1: North America Pharmacovigilance software market, by functionality, 2013 - 2024 (USD Million)
  • TABLE 2: North America pharmacovigilance software market, by delivery mode, 2013 - 2024 (USD Million)
  • TABLE 3: North America Pharmacovigilance software market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 4: U.S. Pharmacovigilance software market, by functionality, 2013 - 2024 (USD Million)
  • TABLE 5: U.S. pharmacovigilance software market, by delivery mode, 2013 - 2024 (USD Million)
  • TABLE 6: U.S. Pharmacovigilance software market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 7: Canada Pharmacovigilance software market, by functionality, 2013 - 2024 (USD Million)
  • TABLE 8: Canada pharmacovigilance software market, by delivery mode, 2013 - 2024 (USD Million)
  • TABLE 9: Canada Pharmacovigilance software market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 10: Europe Pharmacovigilance software market, by functionality, 2013 - 2024 (USD Million)
  • TABLE 11: Europe pharmacovigilance software market, by delivery mode, 2013 - 2024 (USD Million)
  • TABLE 12: Europe Pharmacovigilance software market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 13: UK pharmacovigilance software market, by functionality, 2013 - 2024 (USD Million)
  • TABLE 14: UK pharmacovigilance software market, by delivery mode, 2013 - 2024 (USD Million)
  • TABLE 15: UK Pharmacovigilance software market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 16: Germany pharmacovigilance software market, by functionality, 2013 - 2024 (USD Million)
  • TABLE 17: Germany pharmacovigilance software market, by delivery mode, 2013 - 2024 (USD Million)
  • TABLE 18: Germany Pharmacovigilance software market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 19: Asia Pacific pharmacovigilance software market, by functionality, 2013 - 2024 (USD Million)
  • TABLE 20: Asia Pacific pharmacovigilance software market, by delivery mode, 2013 - 2024 (USD Million)
  • TABLE 21: Asia Pacific pharmacovigilance software market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 22: Japan pharmacovigilance software market, by functionality, 2013 - 2024 (USD Million)
  • TABLE 23: Japan ADR Reporting Software market, by delivery mode, 2013 - 2024 (USD Million)
  • TABLE 24: Japan Pharmacovigilance software market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 25: China pharmacovigilance software market, by functionality, 2013 - 2024 (USD Million)
  • TABLE 26: China pharmacovigilance software market, by delivery mode, 2013 - 2024 (USD Million)
  • TABLE 27: China pharmacovigilance software market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 28: India pharmacovigilance software market, by functionality, 2013 - 2024 (USD Million)
  • TABLE 29: India pharmacovigilance software market, by delivery mode, 2013 - 2024 (USD Million)
  • TABLE 30: India pharmacovigilance software market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 31: Latin America pharmacovigilance software market, by functionality, 2013 - 2024 (USD Million)
  • TABLE 32: Latin America pharmacovigilance software market, by delivery mode, 2013 - 2024 (USD Million)
  • TABLE 33: Latin America pharmacovigilance software market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 34: Brazil pharmacovigilance software market, by functionality, 2013 - 2024 (USD Million)
  • TABLE 35: Brazil pharmacovigilance software market, by delivery mode, 2013 - 2024 (USD Million)
  • TABLE 36: Brazil pharmacovigilance software market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 37: Mexico pharmacovigilance software market, by functionality, 2013 - 2024 (USD Million)
  • TABLE 38: Mexico pharmacovigilance software market, by delivery mode, 2013 - 2024 (USD Million)
  • TABLE 39: Mexico pharmacovigilance software market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 40: MEA pharmacovigilance software market, by functionality, 2013 - 2024 (USD Million)
  • TABLE 41: MEA pharmacovigilance software market, by delivery mode, 2013 - 2024 (USD Million)
  • TABLE 42: MEA Pharmacovigilance software market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 43: South Africa pharmacovigilance software market, by functionality, 2013 - 2024 (USD Million)
  • TABLE 44: South Africa pharmacovigilance software market, by delivery mode, 2013 - 2024 (USD Million)
  • TABLE 45: South Africa pharmacovigilance software market, by end-use, 2013 - 2024 (USD Million)

List of Figures

  • FIG. 1: Market summary
  • FIG. 2: Market trends & outlook
  • FIG. 3: Market segmentation & scope
  • FIG. 4: Market driver relevance analysis (Current & future impact)
  • FIG. 5: Per capita health expenditure, USD, (2011 - 2014)
  • FIG. 6: Usage of social media in healthcare.
  • FIG. 7: Market restraint relevance analysis (Current & future impact)
  • FIG. 8: Penetration & Growth Prospect Mapping
  • FIG. 9: Pharmacovigilance softwarePESTLE Analysis
  • FIG. 10: Porter's Five Forces Analysis
  • FIG. 11: Pharmacovigilance software market delivery mode outlook key takeaways
  • FIG. 12: Pharmacovigilance software market: Functionality movement analysis
  • FIG. 13: ADR reporting software market, 2013 - 2024 (USD Million)
  • FIG. 14: Drug safety audits market, 2013 - 2024 (USD Million)
  • FIG. 15: Issue tracking market, 2013 - 2024 (USD Million)
  • FIG. 16: Fully integrated software market, 2013 - 2024 (USD Million)
  • FIG. 17: Pharmacovigilance software market delivery mode outlook key takeaways
  • FIG. 18: Pharmacovigilance software market: Delivery mode movement analysis
  • FIG. 19: On-premise market, 2013 - 2024 (USD Million)
  • FIG. 20: On-demand market, 2013 - 2024 (USD Million)
  • FIG. 21: Pharmacovigilance software market end-use outlook: key takeaways
  • FIG. 22: Pharmacovigilance software market: End-use movement analysis
  • FIG. 23: Pharma & biotech companies market, 2013 - 2024 (USD Million)
  • FIG. 24: CRO market, 2013 - 2024 (USD Million)
  • FIG. 25: BPO market, 2013 - 2024 (USD Million)
  • FIG. 26: Others market, 2013 - 2024 (USD Million)
  • FIG. 27: Regional market place: Key takeaways
  • FIG. 28: Regional outlook, 2015 & 2024
  • FIG. 29: North America pharmacovigilance software market, 2013 - 2024 (USD Million)
  • FIG. 30: U.S. Pharmacovigilance software market, 2013 - 2024 (USD Million)
  • FIG. 31: Canada Pharmacovigilance software market, 2013 - 2024 (USD Million)
  • FIG. 32: Europe Pharmacovigilance software market, 2013 - 2024 (USD Million)
  • FIG. 33: UK Pharmacovigilance software market, 2013 - 2024 (USD Million)
  • FIG. 34: Germany Pharmacovigilance software market, 2013 - 2024 (USD Million)
  • FIG. 35: Asia Pacific Pharmacovigilance software market, 2013 - 2024 (USD Million)
  • FIG. 36: Japan Pharmacovigilance software market, 2013 - 2024 (USD Million)
  • FIG. 37: China Pharmacovigilance software market, 2013 - 2024 (USD Million)
  • FIG. 38: India Pharmacovigilance software market, 2013 - 2024 (USD Million)
  • FIG. 39: Latin America Pharmacovigilance software market, 2013 - 2024 (USD Million)
  • FIG. 40: Brazil Pharmacovigilance software market, 2013 - 2024 (USD Million)
  • FIG. 41: Mexico Pharmacovigilance software market, 2013 - 2024 (USD Million)
  • FIG. 42: MEA Pharmacovigilance software market, 2013 - 2024 (USD Million)
  • FIG. 43: South Africa Pharmacovigilance software market, 2013 - 2024 (USD Million)
Back to Top